List Results  
  Refine Search  
  Results by Topic  
  Results on Map  
  Search Details  
Found 127 studies with search of:   "Organon" [Exact]
Hide studies that are not seeking new volunteers.
  Display Options
Rank Status Study
1 Completed Comparison of Rocuronium and Org 25969 With Cisatracurium and Neostigmine (19.4.310)(COMPLETED)
Condition: Anesthesia, General
Interventions: Drug: Sugammadex;   Drug: neostigmine
2 Completed To Investigate Efficacy and Safety of a Single Injection of Org 36286 for Ovarian Stimulation Using Daily Recombinant FSH as Reference (Engage)(Study 38819AM1)
Condition: In Vitro Fertilization
Interventions: Drug: corifollitropin alfa;   Drug: follitropin beta
3 Completed Efficacy and Safety of Asenapine With Placebo and Haloperidol (41023)(COMPLETED)
Condition: Schizophrenia
Interventions: Drug: Asenapine;   Drug: Asenapine;   Drug: Haloperidol;   Other: Placebo arm
4 Completed Investigate Dose of Org 36286 to Initiate Multiple Follicular Growth in a Controlled Ovarian Hyperstimulation Protocol for IVF or IVF/ICSI (Study 38807)
Conditions: Infertility;   In Vitro Fertilization
Interventions: Drug: Corifollitropin Alfa;   Drug: Puregon®;   Drug: Orgalutran®
5 Terminated A Trial to Investigate the Effectiveness and Safety of Org 3236 (Etonogestrel) Tablets in Men With Urinary Complaints Suggestive of a Benign Enlargement of the Prostate (304001)(TERMINATED)
Condition: Benign Prostatic Hyperplasia (BPH)
Interventions: Drug: etonogestrel;   Drug: Placebo
6 Completed A Trial to Assess the Pharmacokinetic Profile (e.g., Uptake, Distribution and Excretion of a Substance in the Body) of Nomegestrol Acetate (NOMAC), Estradiol (E2) and Estrone (E1) After Multiple and Single Dose Administration of the Combined Oral Contraception NOMAC-E2
Condition: Healthy
Intervention: Drug: nomegestrol acetate and estradiol
7 Completed A Phase 2, Trial to Investigate the Dose-Response Relationship of a Single Injection of Org 36286 (Corifollitropin Alfa) to Initiate Multiple Follicular Growth in a Controlled Ovarian (Study 38826)
Condition: Fertilization
Interventions: Drug: corifollitropin alfa;   Drug: Follitropin beta injection
8 Completed Tibolone Endometrium Study (Study 32972)(COMPLETED)
Condition: Postmenopausal Women
Interventions: Drug: tibolone;   Drug: Tibolone 2.5 mg;   Drug: CE/MPA
9 Completed 40 Week Trial to Study the Safety of Asenapine When Added to Lithium or Valproate in the Treatment of Bipolar Disorder (A7501009)(COMPLETED)
Condition: Bipolar Disorder
Interventions: Drug: Asenapine;   Drug: Placebo
10 Completed A Bridging Trial Comparing Org 25969 at Reappearance of T2 in Japanese and Caucasian Subjects. Part A: Japanese Subjects (19.4.208A)(COMPLETED)
Condition: Anesthesia, General
Interventions: Drug: sugammadex;   Drug: Placebo
11 Active, not recruiting Study to Investigate Safety and Effectiveness in Treatment of Insomnia (176001)
Condition: Insomnia
Interventions: Drug: Org 50081;   Drug: Placebo
12 Completed Use of Sugammadex Administered at 5 Minutes After Administration of 1.2 mg/kg Esmeron® (19.4.205)(COMPLETED)
Condition: Anesthesia, General
Interventions: Drug: sugammadex;   Drug: Placebo
13 Completed A Study to Investigate the Contraceptive Efficacy and Safety of a Subdermal Etonogestrel Implant (Implanon®)(Study E-1729)(COMPLETED)
Condition: Contraception
Intervention: Drug: etonogestrel implant (Implanon)
14 Active, not recruiting Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial 38819 (Care Program) (Study 38821)
Conditions: Pregnancy;   Neonates
Interventions: Drug: Org 36286;   Drug: recFSH
15 Completed Evaluation of Safety and Efficacy of Org 25969 in Subjects With or Having a Past History of Pulmonary Disease (19.4.308)(COMPLETED)
Condition: Anesthesia, General
Interventions: Drug: Sugammadex 2.0 mg/kg;   Drug: Sugammadex 4.0 mg/kg
16 Recruiting Comparison of 4.0 mg/kg Sugammadex at 1-2 PTC in Renal or Control Patients (19.4.328)
Condition: Anesthesia
Intervention: Drug: sugammadex
17 Completed Efficacy and Safety of Asenapine With Placebo and Olanzapine
Condition: Schizophrenia
Interventions: Drug: asenapine;   Drug: Placebo;   Drug: olanzapine
18 Completed Comparison of Org 25969 With Neostigmine as Reversal Agents for Rocuronium or Vecuronium at Reappearance of T2 (19.4.301)(COMPLETED)
Condition: Anesthesia, General
Interventions: Drug: Sugammadex;   Drug: neostigmine
19 Completed Comparison of Org 25969 in Elderly Subjects With Adult Subjects (19.4.305)(COMPLETED)
Condition: Anesthesia, General
Intervention: Drug: Sugammadex
20 Completed A Bridging Trial Comparing Org 25969 at Reappearance of T2 in Japanese and Caucasian Subjects. Part B: Caucasian Subjects (19.4.208B)(COMPLETED)
Condition: Anesthesia, General
Interventions: Drug: sugammadex (Org 25969);   Drug: Placebo

Previous Page Studies Shown (1-20) Next (21-40)
  RSS Feed for studies found by your search that were received in the last 14 days
  Download Options




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services